HB 1044 Pennsylvania House · 2025-2026 Regular Session

An Act amending Title 35 (Health and Safety) of the Pennsylvania Consolidated Statutes, in epinephrine auto-injector entities, further providing for scope of chapter, for definitions and for epinephrine auto-injectors for authorized entities; and making an editorial change.

HB 1044 allows authorized entities like schools, childcare centers, or sports organizations to stock and use epinephrine delivery systems (e.g., auto-injectors) without requiring individual prescriptions for each person. It permits these entities to acquire devices under a single prescription from a healthcare provider, store them accessibly per FDA guidelines, and train designated staff to recognize anaphylaxis and administer the devices. Staff who complete approved training can use the devices in good faith for anyone showing signs of a severe allergic reaction, regardless of prior diagnosis or prescription. The bill also includes protections for individuals acting in good faith during emergencies.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 25, 2025 Last action Mar 25, 2025